← Torna allo Screener

Alignment Healthcare

ALHC Mid Cap

Healthcare · Healthcare Plans

Aggiornato: May 2, 2026, 22:05 UTC

17,28 €
-10.12% oggi
52W: 9,91 € – 20,36 €
52W Low: 9,91 € Posizione: 70.5% 52W High: 20,36 €

Metriche Chiave

P/E Ratio
202.6x
Rapporto P/E
Forward P/E
28.04x
P/E Forward
P/S Ratio
0.98x
Prezzo/Vendite
EV/EBITDA
56.37x
Valore Impresa/EBITDA
Rendimento Dividendi
Rendimento annuale da dividendi
Cap. di Mercato
3,6 Mrd. €
Capitalizzazione di Mercato
Crescita Ricavi
33.3%
Crescita Ricavi Anno su Anno
Margine di Profitto
0.46%
Margine Netto
ROE
12.53%
Return on Equity
Beta
Sensibilità al mercato
Interesse Corto
12.58%
% del flottante in vendita allo scoperto
Volume Medio
3,308,174
Volume Medio Giornaliero

Analisi della Valutazione

Segnale
Sopravvalutata
vs. P/E medio S&P 500 (24,7x)
Consenso degli Analisti
Acquisto Forte
13 analisti
Prezzo Obiettivo Medio
21,79 €
+26.05% potenziale
Range Obiettivo
16,21 € – 25,59 €

Informazioni sull'Azienda

Settore: Healthcare Industria: Healthcare Plans Paese: United States Dipendenti: 1,849 Borsa: NMS

Alignment Healthcare Stock at a Glance

Alignment Healthcare (ALHC) is currently trading at 17,28 € with a market capitalization of 3,6 Mrd. €. The trailing P/E ratio stands at 202.6x, with a forward P/E of 28.04x. The 52-week range spans from 9,91 € to 20,36 €; the current price is 15.1% below the yearly high. Year-over-year revenue growth stands at +33.3%. The net profit margin stands at 0.46%.

💰 Dividendo

Alignment Healthcare currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Raccomandazioni degli Analisti

13 analysts rate Alignment Healthcare (ALHC) on consensus: Acquisto Forte. The average price target is 21,79 €, implying +26.05% from the current price. Analyst price targets range from 16,21 € to 25,59 €.

Tesi di Investimento: Punti di Forza e Debolezze

Punti di Forza
  • Strong revenue growth of 33.3% YoY
  • Analyst consensus: Strong Buy
  • Positive free cash flow
Debolezze
  • Low profitability (0.46% margin)
  • High valuation multiple (P/E 202.6x)
  • Currently flagged as overvalued
  • High leverage (D/E 159.49)
  • High short interest (12.58%)

Panoramica Tecnica

MM 50 Giorni
16,56 €
+4.38% vs. prezzo
MM 200 Giorni
15,50 €
+11.5% vs. prezzo
Sotto Massimo 52S
−15.1%
20,36 €
Sopra Minimo 52S
+74.4%
9,91 €

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profilo di Rischio

Short Interest
12.58% · High
% del flottante in vendita allo scoperto
Debt-to-Equity
159.49 · Elevated
Debito totale / patrimonio

The data points to elevated short interest (12.58%), higher leverage relative to equity.

Dati di Trading

50-Day MA: 16,56 €
200-Day MA: 15,50 €
Volume: 13,842,177
Volume Medio: 3,308,174
Ratio Corto: 4.91
Rapporto P/B: 20.24x
Debito/Patrimonio: 159.49x
Flusso di Cassa Libero: 203 M €

Where can I buy Alignment Healthcare?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Scroll to Top